|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/06 | (2013.01) |
| A61K 45/06 | (2006.01) | ||
| C07D 413/06 | (2006.01) | ||
| A61K 31/437 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/505 | (2013.01) | ||
| A61K 38/06 | (2006.01) | ||
| A61K 38/12 | (2013.01) | ||
| A61K 38/12 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 51/08 | (2006.01) | ||
| A61K 31/567 | (2013.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61K 31/4745 | (2006.01) | ||
| A61K 31/4745 | (2013.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/513 | (2013.01) | ||
| A61K 38/095 | (2019.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 31/567 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 38/08 | (2019.01) |
| (11) | Number of the document | 3265127 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16759295.5 |
| Date of filing the European patent application | 2016-02-25 | |
| (97) | Date of publication of the European application | 2018-01-10 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/019646 |
| Date | 2016-02-25 |
| (87) | Number | WO 2016/140867 |
| Date | 2016-09-09 |
| (30) | Number | Date | Country code |
| 201562127153 P | 2015-03-02 | US |
| (72) |
MORAITIS, Andreas G. , US
BELANOFF, Joseph K. , US
|
| (73) |
Corcept Therapeutics, Inc. ,
149 Commonwealth Drive, Menlo Park CA 94025,
US
|
| (54) | MIFEPRISTONE AND OCTREOTIDE FOR USE IN THE TREATMENT OF CUSHING'S SYNDROME IN A PATIENT HAVING AN ADRENOCORTICOTROPIC HORMONE (ACTH)-SECRETING PANCREATIC NEUROENDOCRINE TUMOR |
| MIFEPRISTONE AND OCTREOTIDE FOR USE IN THE TREATMENT OF CUSHING'S SYNDROME IN A PATIENT HAVING AN ADRENOCORTICOTROPIC HORMONE (ACTH)-SECRETING PANCREATIC NEUROENDOCRINE TUMOR |